_id
691482c6ccc777a4e85d93f0
Ticker
NMTRQ
Name
9 Meters Biopharma Inc.
Exchange
PINK
Address
4509 Creedmoor Road, Raleigh, NC, United States, 27612
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.9meters.com
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-05T11:31:19.911Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1445
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-03-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
12787491
Operating Income
-12787491
Interest Expense
752820
Pretax Income
-13868457
Net Income
-13868457
Eps
-0.9673627663821964
Dividends Per Share
-
Shares Outstanding
14459690
Income Tax Expense
-
EBITDA
-13114308
Operating Margin
-
Total Other Income Expense Net
-492933
Cash
6938991
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
9197303
Property Plant Equipment
106754
Total Assets
9313037
Payables
4231034
Short Term Debt
-
Long Term Debt
-
Total Liabilities
15612242
Equity
-6299205
Bs_currency_symbol
USD
Depreciation
1329
Change In Working Capital
2308621
Cash From Operations
-9749676
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-12285678
Net Change In Cash
-22035354
Cf_currency_symbol
USD
PE
-
PB
-0.0002275899260303483
ROE
220.16202044543718
ROA
-148.91444112162338
FCF
-9749676
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2023-03-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
12787491
Quarters > 0 > income Statement > operating Income
-12787491
Quarters > 0 > income Statement > interest Expense
752820
Quarters > 0 > income Statement > pretax Income
-13868457
Quarters > 0 > income Statement > net Income
-13868457
Quarters > 0 > income Statement > eps
-0.9673627663821964
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
14336356
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13114308
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-492933
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6938991
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
9197303
Quarters > 0 > balance Sheet > property Plant Equipment
106754
Quarters > 0 > balance Sheet > total Assets
9313037
Quarters > 0 > balance Sheet > payables
4231034
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15612242
Quarters > 0 > balance Sheet > equity
-6299205
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-13868457
Quarters > 0 > cash Flow > depreciation
1329
Quarters > 0 > cash Flow > change In Working Capital
2308621
Quarters > 0 > cash Flow > cash From Operations
-9749676
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-12285678
Quarters > 0 > cash Flow > net Change In Cash
-22035354
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.9673627663821964
Quarters > 0 > ratios > PB
-0.0002275899260303483
Quarters > 0 > ratios > ROE
220.16202044543718
Quarters > 0 > ratios > ROA
-148.91444112162338
Quarters > 0 > ratios > FCF
-9749676
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2022-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
10741396
Quarters > 1 > income Statement > operating Income
-10741396
Quarters > 1 > income Statement > interest Expense
1819644
Quarters > 1 > income Statement > pretax Income
-11929903
Quarters > 1 > income Statement > net Income
-11929903
Quarters > 1 > income Statement > eps
-0.9151255918448377
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13036356
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-10107719
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
339697
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
12646282
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
33017849
Quarters > 1 > balance Sheet > property Plant Equipment
122715
Quarters > 1 > balance Sheet > total Assets
33147844
Quarters > 1 > balance Sheet > payables
5053073
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
30747301
Quarters > 1 > balance Sheet > equity
2400543
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-11929900
Quarters > 1 > cash Flow > depreciation
2540
Quarters > 1 > cash Flow > change In Working Capital
452852
Quarters > 1 > cash Flow > cash From Operations
-9738610
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-12285678
Quarters > 1 > cash Flow > net Change In Cash
-9738610
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.9151255918448377
Quarters > 1 > ratios > PB
0.0005430586329842874
Quarters > 1 > ratios > ROE
-496.9668529161944
Quarters > 1 > ratios > ROA
-35.989981731541874
Quarters > 1 > ratios > FCF
-9738610
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2022-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
8715985
Quarters > 2 > income Statement > operating Income
-8715985
Quarters > 2 > income Statement > interest Expense
847341
Quarters > 2 > income Statement > pretax Income
-9354671
Quarters > 2 > income Statement > net Income
-9354671
Quarters > 2 > income Statement > eps
-0.7220628087834021
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12955481
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8505761
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
77000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
15860966
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
18453599
Quarters > 2 > balance Sheet > property Plant Equipment
139453
Quarters > 2 > balance Sheet > total Assets
42135208
Quarters > 2 > balance Sheet > payables
1437685
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
15744057
Quarters > 2 > balance Sheet > total Liabilities
28674407
Quarters > 2 > balance Sheet > equity
13460801
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-9354670
Quarters > 2 > cash Flow > depreciation
1569
Quarters > 2 > cash Flow > change In Working Capital
-1770201
Quarters > 2 > cash Flow > cash From Operations
-9969952
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
19911706
Quarters > 2 > cash Flow > net Change In Cash
9941754
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.7220628087834021
Quarters > 2 > ratios > PB
0.00009624598863024571
Quarters > 2 > ratios > ROE
-69.4956488844906
Quarters > 2 > ratios > ROA
-22.201554101738385
Quarters > 2 > ratios > FCF
-9969952
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2022-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
11195421
Quarters > 3 > income Statement > operating Income
-11195421
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-11130102
Quarters > 3 > income Statement > net Income
-11130102
Quarters > 3 > income Statement > eps
-0.8591111530671184
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12955369
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-11127315
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
29455788
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
31348098
Quarters > 3 > balance Sheet > property Plant Equipment
154800
Quarters > 3 > balance Sheet > total Assets
31508478
Quarters > 3 > balance Sheet > payables
2326017
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9423006
Quarters > 3 > balance Sheet > equity
22085472
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-11130100
Quarters > 3 > cash Flow > depreciation
2787
Quarters > 3 > cash Flow > change In Working Capital
1066991
Quarters > 3 > cash Flow > cash From Operations
-7786324
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
19911706
Quarters > 3 > cash Flow > net Change In Cash
-7786324
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.8591111530671184
Quarters > 3 > ratios > PB
0.000058660140928842276
Quarters > 3 > ratios > ROE
-50.39558131245735
Quarters > 3 > ratios > ROA
-35.32414990022686
Quarters > 3 > ratios > FCF
-7786324
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
42017051
Annuals > 0 > income Statement > operating Income
-42017051
Annuals > 0 > income Statement > interest Expense
2667289
Annuals > 0 > income Statement > pretax Income
-43766415
Annuals > 0 > income Statement > net Income
-43766415
Annuals > 0 > income Statement > eps
-3.357258347347986
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13036356
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-41090603
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
416697
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
12646282
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
33017849
Annuals > 0 > balance Sheet > property Plant Equipment
122715
Annuals > 0 > balance Sheet > total Assets
33147844
Annuals > 0 > balance Sheet > payables
5053073
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
30747301
Annuals > 0 > balance Sheet > equity
2400543
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-43766415
Annuals > 0 > cash Flow > depreciation
8523
Annuals > 0 > cash Flow > change In Working Capital
661423
Annuals > 0 > cash Flow > cash From Operations
-37243217
Annuals > 0 > cash Flow > capital Expenditures
2842
Annuals > 0 > cash Flow > cash From Investing
-2842
Annuals > 0 > cash Flow > cash From Financing
19911706
Annuals > 0 > cash Flow > net Change In Cash
-17334353
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.357258347347986
Annuals > 0 > ratios > PB
0.0005430586329842874
Annuals > 0 > ratios > ROE
-1823.1881286858847
Annuals > 0 > ratios > ROA
-132.0339718022083
Annuals > 0 > ratios > FCF
-37246059
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
31658166
Annuals > 1 > income Statement > operating Income
-31658166
Annuals > 1 > income Statement > interest Expense
47188
Annuals > 1 > income Statement > pretax Income
-36779400
Annuals > 1 > income Statement > net Income
-36779400
Annuals > 1 > income Statement > eps
-2.8485172830680843
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12911770
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-36724639
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-5096753
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
46993285
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
49985233
Annuals > 1 > balance Sheet > property Plant Equipment
182712
Annuals > 1 > balance Sheet > total Assets
50173525
Annuals > 1 > balance Sheet > payables
2434452
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8570212
Annuals > 1 > balance Sheet > equity
41603313
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-36779400
Annuals > 1 > cash Flow > depreciation
7573
Annuals > 1 > cash Flow > change In Working Capital
2232981
Annuals > 1 > cash Flow > cash From Operations
-29478275
Annuals > 1 > cash Flow > capital Expenditures
12476
Annuals > 1 > cash Flow > cash From Investing
-2430641
Annuals > 1 > cash Flow > cash From Financing
41050813
Annuals > 1 > cash Flow > net Change In Cash
9141897
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.8485172830680843
Annuals > 1 > ratios > PB
0.000031035437009547775
Annuals > 1 > ratios > ROE
-88.4049787092677
Annuals > 1 > ratios > ROA
-73.30439708989951
Annuals > 1 > ratios > FCF
-29490751
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
21452978
Annuals > 2 > income Statement > operating Income
-21452978
Annuals > 2 > income Statement > interest Expense
4046223
Annuals > 2 > income Statement > pretax Income
-61496489
Annuals > 2 > income Statement > net Income
-61496489
Annuals > 2 > income Statement > eps
-6.010533303529812
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
10231453
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-57431775
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-36016280
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
37851388
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
38926975
Annuals > 2 > balance Sheet > property Plant Equipment
225958
Annuals > 2 > balance Sheet > total Assets
39158513
Annuals > 2 > balance Sheet > payables
1487948
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7016400
Annuals > 2 > balance Sheet > equity
32142113
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-61496490
Annuals > 2 > cash Flow > depreciation
18491
Annuals > 2 > cash Flow > change In Working Capital
775489
Annuals > 2 > cash Flow > cash From Operations
-19409786
Annuals > 2 > cash Flow > capital Expenditures
2543
Annuals > 2 > cash Flow > cash From Investing
-3186997
Annuals > 2 > cash Flow > cash From Financing
55855239
Annuals > 2 > cash Flow > net Change In Cash
33258456
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-6.010533303529812
Annuals > 2 > ratios > PB
0.000031831924055521805
Annuals > 2 > ratios > ROE
-191.32683965114552
Annuals > 2 > ratios > ROA
-157.04500576924357
Annuals > 2 > ratios > FCF
-19412329
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
24282781
Annuals > 3 > income Statement > operating Income
-24282781
Annuals > 3 > income Statement > interest Expense
1825148
Annuals > 3 > income Statement > pretax Income
-27048808
Annuals > 3 > income Statement > net Income
-27048808
Annuals > 3 > income Statement > eps
-13.70334918533672
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1973883
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-25202053
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1126146
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4592932
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
5222984
Annuals > 3 > balance Sheet > property Plant Equipment
68252
Annuals > 3 > balance Sheet > total Assets
5296816
Annuals > 3 > balance Sheet > payables
3890094
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
14910830
Annuals > 3 > balance Sheet > equity
-9614014
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-27048808
Annuals > 3 > cash Flow > depreciation
21607
Annuals > 3 > cash Flow > change In Working Capital
3894628
Annuals > 3 > cash Flow > cash From Operations
-17967992
Annuals > 3 > cash Flow > capital Expenditures
11934
Annuals > 3 > cash Flow > cash From Investing
-11934
Annuals > 3 > cash Flow > cash From Financing
16843958
Annuals > 3 > cash Flow > net Change In Cash
-1135968
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-13.70334918533672
Annuals > 3 > ratios > PB
-0.000020531309815026275
Annuals > 3 > ratios > ROE
281.34770762763605
Annuals > 3 > ratios > ROA
-510.6616503197393
Annuals > 3 > ratios > FCF
-17979926
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.9673627663821964
Valuation > metrics > PB
-0.0002275899260303483
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
220.16202044543718
Profitability > metrics > ROA
-150.78830174454401
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-16.98612018809277
Risk > final Score
-38
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.1737719432176625
Liquidity > metrics > Quick Ratio
2.1737719432176625
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-18
Prev Risks > 1
-23
Prev Risks > 2
-16008
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:17:22.506Z
Earnings History > 0 > period
2023-03-31
Earnings History > 0 > report Date
2023-05-15
Earnings History > 0 > date
2023-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-1.02
Earnings History > 0 > eps Estimate
-0.78
Earnings History > 0 > eps Difference
-0.24
Earnings History > 0 > surprise Percent
-30.7692
Earnings History > 1 > period
2022-12-31
Earnings History > 1 > report Date
2023-03-28
Earnings History > 1 > date
2022-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.92
Earnings History > 1 > eps Estimate
-0.7683
Earnings History > 1 > eps Difference
-0.1517
Earnings History > 1 > surprise Percent
-19.7449
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-11-08
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.72
Earnings History > 2 > eps Estimate
-0.82
Earnings History > 2 > eps Difference
0.1
Earnings History > 2 > surprise Percent
12.1951
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-08-15
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.04
Earnings History > 3 > eps Estimate
-0.0417
Earnings History > 3 > eps Difference
0.0017
Earnings History > 3 > surprise Percent
4.0767
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-05-16
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.04
Earnings History > 4 > eps Estimate
-0.04
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-23
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.04
Earnings History > 5 > eps Estimate
-0.036
Earnings History > 5 > eps Difference
-0.004
Earnings History > 5 > surprise Percent
-11.1111
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-11-15
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.05
Earnings History > 6 > eps Estimate
-0.04
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-25
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-08-13
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.03
Earnings History > 7 > eps Estimate
-0.03
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-05-13
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.03
Earnings History > 8 > eps Estimate
-0.03
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-03-22
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.03
Earnings History > 9 > eps Estimate
-0.04
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
25
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-11-10
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.06
Earnings History > 10 > eps Estimate
-0.06
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-08-13
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.57
Earnings History > 11 > eps Estimate
-0.16
Earnings History > 11 > eps Difference
-0.41
Earnings History > 11 > surprise Percent
-256.25
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-05-13
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.07
Earnings History > 12 > eps Estimate
-0.13
Earnings History > 12 > eps Difference
0.06
Earnings History > 12 > surprise Percent
46.1538
Earnings History > 13 > period
2019-12-31
Earnings History > 13 > report Date
2020-03-11
Earnings History > 13 > date
2019-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.25
Earnings History > 13 > eps Estimate
-0.13
Earnings History > 13 > eps Difference
-0.12
Earnings History > 13 > surprise Percent
-92.3077
Earnings History > 14 > period
2019-09-30
Earnings History > 14 > report Date
2019-11-12
Earnings History > 14 > date
2019-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.26
Earnings History > 14 > eps Estimate
-0.14
Earnings History > 14 > eps Difference
-0.12
Earnings History > 14 > surprise Percent
-85.7143
Earnings History > 15 > period
2019-06-30
Earnings History > 15 > report Date
2019-08-08
Earnings History > 15 > date
2019-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.13
Earnings History > 15 > eps Estimate
-0.13
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2019-03-31
Earnings History > 16 > report Date
2019-05-13
Earnings History > 16 > date
2019-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.16
Earnings History > 16 > eps Estimate
-0.12
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-33.3333
Earnings History > 17 > period
2018-12-31
Earnings History > 17 > report Date
2019-03-19
Earnings History > 17 > date
2018-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.11
Earnings History > 17 > eps Estimate
-0.11
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-11-13
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.03
Earnings History > 18 > eps Estimate
-0.17
Earnings History > 18 > eps Difference
0.14
Earnings History > 18 > surprise Percent
82.3529
Earnings History > 19 > period
2018-06-30
Earnings History > 19 > report Date
2018-08-15
Earnings History > 19 > date
2018-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.16
Earnings History > 19 > eps Estimate
-0.26
Earnings History > 19 > eps Difference
0.1
Earnings History > 19 > surprise Percent
38.4615
Earnings History > 20 > period
2018-03-31
Earnings History > 20 > report Date
2018-05-30
Earnings History > 20 > date
2018-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.76
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.76
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2017-12-31
Earnings History > 21 > report Date
2018-03-14
Earnings History > 21 > date
2017-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-2.95
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-2.95
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-09-30
Earnings History > 22 > report Date
2017-11-08
Earnings History > 22 > date
2017-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.61
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-1.61
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-06-30
Earnings History > 23 > report Date
2017-08-21
Earnings History > 23 > date
2017-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.94
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-1.94
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-03-31
Earnings History > 24 > report Date
2017-05-19
Earnings History > 24 > date
2017-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-2.8
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-2.8
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-12-31
Earnings History > 25 > report Date
2016-12-31
Earnings History > 25 > date
2016-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-34.1662
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2016-09-30
Earnings History > 26 > report Date
2016-09-30
Earnings History > 26 > date
2016-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-53.0902
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A9 Meters calls it quits after measuring options, reports just $150K in cash - Fierce Biotech
7/19/2023
9 Meters calls it quits after measuring options, reports just $150K in cash Fierce Biotech
Read more →9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K) marketscreener.com
Read more →(Last Updated 2023-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of 9 Meters Biopharma Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-03-31
EPS Actual
-1.02
EPS Estimate
-0.78
EPS Difference
-0.24
Surprise Percent
-30.7692%
(Last Updated 2023-03-31)
(Last Updated 2023-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.